The role of LncRNAs in tumor immunotherapy

Cancer immunotherapy is a major breakthrough in the history of tumor therapy in the last decade. Immune checkpoint inhibitors blocking CTLA-4/B7 or PD-1/PD-L1 pathways have greatly prolonged the survival of patients with different cancers. Long non-coding RNAs (lncRNAs) are abnormally expressed in t...

Descripción completa

Detalles Bibliográficos
Autores principales: Pan, Xuan, Li, Chenchen, Feng, Jifeng
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2023
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9942365/
https://www.ncbi.nlm.nih.gov/pubmed/36810034
http://dx.doi.org/10.1186/s12935-023-02872-3

Ejemplares similares

Ejemplares similares